People familiar with the matter revealed that the French government is considering a number of options, including the state-owned investment bank Banque de France buying shares in Opella, Sanofi's consumer health division. The department sells over-the-counter medicines, including the pain reliever dolipran, which is the most commonly used drug in France. Previously, private equity giant Clayton Dubilier & Rice is about to acquire Sanofi's consumer health division Opella for about 15 billion euros. People familiar with the matter quoted the Ministry of Finance as saying that there will be a screening process, and unauthorized transactions will not be carried out.

People familiar with the matter revealed that the French government is considering a number of options, including the state-owned investment bank Banque de France buying shares in Opella, Sanofi's consumer health division. The department sells over-the-counter medicines, including the pain reliever dolipran, which is the most commonly used drug in France. Previously, private equity giant Clayton Dubilier & Rice is about to acquire Sanofi's consumer health division Opella for about 15 billion euros. People familiar with the matter quoted the Ministry of Finance as saying that there will be a screening process, and unauthorized transactions will not be carried out.